+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Urinary Tract Infection Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4825610
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

FEATURED COMPANIES

  • Allergan plc
  • AstraZeneca plc
  • Bayer AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mylan N.V.
  • MORE
The report on the global urinary tract infection market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global urinary tract infection market to grow with a CAGR of 3.5% over the forecast period from 2019-2025. The study on urinary tract infection market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on urinary tract infection market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the urinary tract infection market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global urinary tract infection market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Rising prevalence of urinary tract infection (UTI) globally
  • Rising hospital borne infections and growing geriatric population
2) Restraints
  • Unmet clinical requirements, and increasing market fragmentation can hamper the growth of the market
3) Opportunities
  • Rising awareness about women health provides better opportunities to the market
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global urinary tract infection market is segmented on the basis of drug class, clinical indications, and end user.

The Global Urinary Tract Infection Market by Drug Class
  • Quinolones
  • Aminoglycosides
  • β-lactam
  • Azoles
  • Other Drug Class
The Global Urinary Tract Infection Market by Clinical Indications
  • Cystitis
  • Urethritis
  • Pyelonephritis
  • Other Clinical Indications
The Global Urinary Tract Infection Market by End User
  • Hospitals
  • Self-administered
  • Other End User
Company Profiles
The companies covered in the report include
  • Merck & Co., Inc.
  • Bayer AG
  • Johnson & Johnson
  • Novartis AG
  • Allergan plc
  • AstraZeneca plc
  • Mylan N.V.
  • Novo Nordisk A/S
  • Sun Pharmaceuticals ltd.
  • Other companies
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the urinary tract infection market.
2. Complete coverage of all the segments in the urinary tract infection market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the urinary tract infection market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan plc
  • AstraZeneca plc
  • Bayer AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mylan N.V.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Urinary Tract Infection Market Highlights
2.2. Urinary Tract Infection Market Projection
2.3. Urinary Tract Infection Market Regional Highlights

3. Global Urinary Tract Infection Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Drug Class
3.4.2. Growth Matrix Analysis by Clinical Indications
3.4.3. Growth Matrix Analysis by End User
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Urinary Tract Infection Market

4. Global Urinary Tract Infection Market Macro Indicator Analysis

5. Global Urinary Tract Infection Market by Drug Class
5.1. Quinolones
5.2. Aminoglycosides
5.3. β-lactam
5.4. Azoles
5.5. Other Drug Class

6. Global Urinary Tract Infection Market by Clinical Indications
6.1. Cystitis
6.2. Urethritis
6.3. Pyelonephritis
6.4. Other Clinical Indications

7. Global Urinary Tract Infection Market by End User
7.1. Hospitals
7.2. Self-administered
7.3. Other End Users

8. Global Urinary Tract Infection Market by Region 2019-2025
8.1. North America
8.1.1. North America Urinary Tract Infection Market by Drug Class
8.1.2. North America Urinary Tract Infection Market by Clinical Indications
8.1.3. North America Urinary Tract Infection Market by End User
8.1.4. North America Urinary Tract Infection Market by Country
8.2. Europe
8.2.1. Europe Urinary Tract Infection Market by Drug Class
8.2.2. Europe Urinary Tract Infection Market by Clinical Indications
8.2.3. Europe Urinary Tract Infection Market by End User
8.2.4. Europe Urinary Tract Infection Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Urinary Tract Infection Market by Drug Class
8.3.2. Asia-Pacific Urinary Tract Infection Market by Clinical Indications
8.3.3. Asia-Pacific Urinary Tract Infection Market by End User
8.3.4. Asia-Pacific Urinary Tract Infection Market by Country
8.4. RoW
8.4.1. RoW Urinary Tract Infection Market by Drug Class
8.4.2. RoW Urinary Tract Infection Market by Clinical Indications
8.4.3. RoW Urinary Tract Infection Market by End User
8.4.4. RoW Urinary Tract Infection Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive landscape in the global urinary tract infection market
9.2. Companies Profiles
9.2.1. Merck & Co., Inc.
9.2.2. Bayer AG
9.2.3. Johnson & Johnson
9.2.4. Novartis AG
9.2.5. Allergan plc
9.2.6. AstraZeneca plc
9.2.7. Mylan N.V.
9.2.8. Novo Nordisk A/S
9.2.9. Sun Pharmaceuticals ltd.
9.2.10. Other companies

10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Merck & Co., Inc.
  • Bayer AG
  • Johnson & Johnson
  • Novartis AG
  • Allergan plc
  • AstraZeneca plc
  • Mylan N.V.
  • Novo Nordisk A/S
  • Sun Pharmaceuticals ltd.
Note: Product cover images may vary from those shown
Adroll
adroll